Skip to content

An Alternative Treatment for Parkinson’s Patients

An Alternative Treatment for Parkinson’s Patients

April is Parkinson’s Awareness Month and an opportune time to highlight the disease and how medical marijuana may be a beneficial treatment option for those living with the condition. Many Parkinson’s patients find themselves desperate for alternative treatment options that provide sufficient relief of their symptoms and help avoid or postpone the need for surgery down the road.

Understanding Parkinson’s

“Parkinson’s disease (PD) is a neurodegenerative disorder that affects predominantly dopamine-producing (“dopaminergic”) neurons in a specific area of the brain called the substantia nigra.” (parkinson.org). Symptoms of PD usually form over many years and the progression can vary from person to person. Some patients with PD may experience one or all of the following:

  • Tremors, mainly when resting
  • Bradykinesia, slow movements
  • Limb rigidity, stiffness of the arms or legs beyond general aging or arthritis
  • Gait and balance problems

In early signs of PD, patients may experience little to no expression on one side of the face, limited arm movement or soft or slurred speech. Overtime, the symptoms of Parkinson’s will increase. (mayoclinic.org) When diagnosing a patient with Parkinson’s, physicians will look at the patient’s medical history, review their signs and symptoms and conduct neurological and physical exams.  

Current Treatments of Parkinson’s

Unfortunately, the cause of PD remains unknown with no known cure. However, medications and surgery do help reduce the symptoms. Parkinson’s may not directly cause death in patients, but complications from the disease can be very serious. “The Centers for Disease Control and Prevention (CDC) rated complications from PD as the 14th cause of death in the United States.” (parkinson.org).

In addition to medications and possible surgeries, physicians may suggest various lifestyle changes for their patients to help improve quality of life. “In some cases, physical therapy that focuses on balance and stretching is also important. A speech-language pathologist may help improve speech problems.” (mayoclinic.org)

Treating with Medical Cannabis

Although the medications that physicians prescribe to their patients can be helpful, there still seems to be a gap in the efficacy of these medications. Patients with PD are often eager to find alternative methods to help subdue their symptoms, which leads many to look into the therapeutic capabilities of medical marijuana.

“Our bodies make natural cannabinoids that control sleep, appetite, mood and other processes by binding to receptors throughout the body and brain. These receptors are found in particularly high numbers in the basal ganglia, a circuit of brain cells that controls movement and is affected in Parkinson’s. Because the cannabinoids in marijuana bind to the receptors in our body and brain, researchers have looked at whether they could bind to basal ganglia and other receptors to modify the course of PD or help ease symptoms of disease.” – michealjfox.org

Despite the constant struggle to get medical marijuana into clinical trials, a handful have been conducted based on the effects medical cannabis has on decreasing motor/non-motor symptoms and levodopa-induced dyskinesia (involuntary movements that may result with long-term use of levodopa and many years of living with PD). Unfortunately, due to strict federal restrictions, there is insufficient evidence to definitively say that medical marijuana and cannabinoids are an effective treatment for Parkinson’s. However, it’s recognized that there could be substantial benefit to introducing the plant into a PD patient’s treatment plan if they’re the right fit.

Interested in treating your patients with medical marijuana, but worried you don’t currently have enough credible data to do so? Join Arfinn Med for FREE to get real medical marijuana treatment efficacies, discuss treatment options with other licensed physicians and stay up-to-date on all of the latest industry findings.

Sources: https://www.parkinson.org/Understanding-Parkinsons/What-is-Parkinsons/Young-Onset-Parkinsons

https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/diagnosis-treatment/drc-20376062
https://www.apdaparkinson.org/article/medical-marijuana-and-parkinsons-disease/https://www.michaeljfox.org/foundation/news-detail.php?ask-the-md-medical-marijuana-and-parkinson-disease-a

Stories you may be interested in

Doctors and patients are flying blind as medical marijuana use rises, research lags

Marijuana’s role in the health care universe has grown exponentially over the past few years. Currently, 33 U.S. states have legalized the use of medical marijuana, and more and more states are considering making it legal for recreational purposes as well. As cannabis becomes more accessible, many people are turning to tetrahydrocannabinol (THC) and cannabidiol (CBD) products to…
Read More

Finally, Georgia can grow medical marijuana. Here’s what you need to know.

Four years ago, Governor Nathan Deal signed into law Haleigh’s Hope Act, which made low-THC cannabis oil legal to use by those with certain medical conditions. However, as it was still against the law to buy or grow marijuana in the state, it was virtually impossible to obtain the oil in Georgia. Patients were forced…
Read More

Medical marijuana users tell their stories to Medical Cannabis Study Commission

Thursday, the Medical Cannabis Study Commission held its third meeting. The Commission has been tasked with presenting a policy recommendation to the legislature on exactly what the best medical marijuana bill should look like. The Commission held a public hearing in which a number of medical marijuana users claimed that the drug has benefitted them.…
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More

Three Key Voices in the Medical Marijuana Industry

As medical marijuana programs continue to expand throughout the United States, it is important to recognize some of the key voices throughout the industry that got us here. These individuals range from researches to physicians and even to patients who started their own advocacy group. Keep reading to learn about just three of the many…
Read More

Insomnia: A Silent Epidemic

The struggle to get a good night’s sleep is something many adults can relate to, but what if there was a natural alternative to keep those sheep jumping all night long? CBD, also known as cannabidiol, has been gaining popularity among patients to help treat pain, anxiety and so much more. Additionally, conditions such as…
Read More

Leave a Comment

You must be logged in to post a comment.